UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000003706 |
|---|---|
| Receipt number | R000004477 |
| Scientific Title | The status of essential trace metals and the efficacy of zinc supplementation in depressive disorders |
| Date of disclosure of the study information | 2010/06/04 |
| Last modified on | 2018/06/12 17:07:26 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The status of essential trace metals and the efficacy of zinc supplementation in depressive disorders
Acronym
A study of the efficacy of zinc supplementation in depressive disorders
Scientific Title
The status of essential trace metals and the efficacy of zinc supplementation in depressive disorders
Scientific Title:Acronym
A study of the efficacy of zinc supplementation in depressive disorders
Region
| Japan |
Condition
Condition
depressive disorders
Classification by specialty
| Psychiatry |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the efficacy of zinc supplementation in patient with depressive disorders that are resistant to conventional treatment.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Serum levels of elements Zn and Cu, albumin, and total protein. Body weight and HAM-D17 score. These will be measured at 0, 4, 8, 12 weeks.
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Administraion of polaprezinc, a zinc-containing product.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 95 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Those with depressive disorders according to DSM-IV-TR criteria, who are considered to be resistant to conventional antidepressant treatment.
Key exclusion criteria
Suicidal score in HAM-D17 is greater than 2.
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Takashi Kudo |
Organization
Osaka University Graduate School of Medicine
Division name
Department of Psychiatry
Zip code
Address
2-2 Yamadaoka, Suita-shi, Osaka-fu 565-0871
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
Osaka University Graduate School of Medicine
Division name
Department of Psychiatry
Zip code
Address
TEL
Homepage URL
kudo@psy.med.osaka-u.ac.jp
Sponsor or person
Institute
Osaka University Graduate School of Medicine, Department of Psychiatry
Institute
Department
Personal name
Funding Source
Organization
Zeria Pharmaceutical Company
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2010 | Year | 06 | Month | 04 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2009 | Year | 03 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2009 | Year | 04 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2010 | Year | 06 | Month | 04 | Day |
Last modified on
| 2018 | Year | 06 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004477
